- The Wall Street Journal•12 days ago
Switzerland’s Lonza Group is purchasing the ingredient maker from Kainos, which originally invested in the company back in late 2013.
- Reuters•last month
Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements. Lonza said the California company's range of products like UC-11 to promote healthy joints would complement its own in sports nutrition, weight management, immune and pet health.
- Associated Press•last month
BERLIN (AP) — Pharmaceutical supplier Lonza of Switzerland says it is buying InterHealth Nutraceuticals, Inc., a California-based company that makes ingredients for use in dietary supplements, in a deal worth up to $300 million.
Lonza Group Ltd (LZAGF)
Other OTC - Other OTC Delayed Price. Currency in USD
At close: 9:30 AM EDT
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||27.58|
|Avg Vol (3m)||0|
|Dividend & Yield||0.00 (0.00%)|